Nasal Vaccines Global Markets and Pipeline Analysis Research Report 2022 Featuring AstraZeneca, BioDiem, BlueWillow Biologics, Meissa Vaccines, & Serum Institute of India
06 janv. 2023 08h33 HE
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Nasal Vaccines: Global Markets and Pipeline Analysis" report has been added to ResearchAndMarkets.com's offering. This report examines trends and...
Global Viral Vector and Plasmid DNA Testing Services Market Size To Surpass USD 602 Million By 2030 | CAGR 25.5 %
13 déc. 2022 12h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Global Viral Vector and Plasmid DNA Testing Services Market Size to grow from USD 78 million in 2021 to USD 602 million by 2030, at a...
World Digital Biomanufacturing Market Development Report 2022: A Shift Toward a Full- Fledged Digitally Equipped Biomanufacturing Unit & Technology Convergence for Seamless Digital Biomanufacturing
09 déc. 2022 07h38 HE
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Developments in Digital Biomanufacturing: Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report...
Global Cell Therapy Technologies Market Report 2022: Development of Cutting-Edge Techniques Driving Sector Forward
08 déc. 2022 05h43 HE
|
Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market Share, Size, Trends, Industry Analysis Report, By Product; By Process; By Cell Type; By End-Use; By Region; Segment...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments
06 déc. 2022 16h05 HE
|
Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $34.8 Million -- -- Signed $26 Million in Net New Business Orders Resulting in a Backlog of $147 Million, an Increase of 23% Year-Over-Year -- -- Mammalian...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022
29 nov. 2022 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Viral Vector Manufacturing Market is expected to generate a revenue of USD 1,733.42 Million by 2028, Globally, at 19.1% CAGR: Verified Market Research®
18 nov. 2022 09h15 HE
|
Verified Market Research
Jersey City, New Jersey, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Viral Vector Manufacturing Market” By Type (Retroviral Vectors, Adenoviral Vectors,...
Biologics Outsourcing Global Market Report 2022: Increased Therapeutic Value and Huge Potential of Biologics Outsourcing Boosts Sector
14 nov. 2022 04h28 HE
|
Research and Markets
Dublin, Nov. 14, 2022 (GLOBE NEWSWIRE) -- The "Biologics Outsourcing Global Market - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The biologics outsourcing global...
Global Exosome-Mediated Drug Delivery Technology Market Research Report 2022: Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
07 nov. 2022 07h48 HE
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Growth Opportunities for Exosome-Mediated Drug Delivery" report has been added to ResearchAndMarkets.com's offering. This research...
Biopharmaceutical Contract Manufacturing Market, 2035 - Shift from One-time Contracts to Strategic Partnerships
19 oct. 2022 05h28 HE
|
Research and Markets
Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of...